FN Kralovske Vinohrady

Prague 10034

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Locally Advanced Head and Neck Squamous Cell Carcinoma, Myelodysplastic Syndromes, Neovascular (Wet) Age-related Macular Degeneration (AMD), Recurrent Head and Neck Squamous Cell Carcinoma, Renal Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck, Type 1 Diabetes Mellitus

Studies at this site

• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] — Completed
• Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHN — Withdrawn before enrolling
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Completed
• A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer — Completed